Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming

EP: 1.PNH Overview and Pathophysiology

EP: 2.Intravascular and Extravascular Hemolysis MoA in PNH

Now Viewing

EP: 3.Utilizing Health Information Technology to Bridge Gaps in PNH Treatment Programming

EP: 4.Key Treatment Considerations for Patients Diagnosed With PNH

EP: 5.Complement System Role in PNH Treatment Approach

EP: 6.Eculizumab Impact on PNH Treatment Landscape and Unmet Needs in PNH Management

EP: 7.Efficacy End Points For PNH Treatment

EP: 8.Efficacy and Safety Trials Results of Complement Inhibitors

EP: 9.Treatment Adherence and Cost Considerations Surrounding Various Routes of PNH Treatment Administration

EP: 10.Investigational Therapies Paving New PNH Treatment Pathways

EP: 11.Key Financial Factors Associated With Typical PNH Treatment Journey

EP: 12.Navigating Transfusion Requirements in PNH Treatment

EP: 13.Considerations for Managing PNH Treatment Complications

EP: 14.Infection Risk Management Counseling For Patients Receiving Treatment for PNH

EP: 15.Ensuring PNH Treatment Access and Adherence to Therapies

EP: 16.Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway

Video content above is prompted by the following:

• What challenges are health care providers commonly faced with regarding the diagnosis and management of paroxysmal nocturnal hemoglobinuria (PNH), given the rarity of the disease and the complexity of its pathophysiology?
• How are electronic health record systems and other health information technology solutions being utilized to aid in the identification of patients with PNH, including those with inadequately controlled disease?
• Please describe the clinical impact and progression of PNH, focusing on the symptoms patients might experience prior to diagnosis, as well as potential complications and comorbidities that may develop over time.